ConductScience.org, home

Paper32835331

Low rate of bacterial co-infection in patients with COVID-19.

Adler H and 4 others. Lancet Microbe, 2020. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Low rate of bacterial co-infection in patients with COVID-19. Papers, record 32835331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32835331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Low rate of bacterial co-infection in patients with COVID-19.
PubMed
Journal
Lancet Microbe
PubMed
Year
2020
PubMed
Publication types
Letter, Comment
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
2.24
iCite
Revised in PubMed
2024-03-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Adler HHugh
2Ball RRobert
3Fisher MMichael
4Mortimer KKalani
5Vardhan MSMadhur S

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial InfectionsMajor topic
COVID-19Major topic
CoinfectionMajor topic
Bacteria
Humans

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on32835323Co-infections: potentially lethal and unexplored in COVID-19.https://conductscience.org/library/papers/32835323

Source PubMed

Download CSV of comments and corrections

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132298228Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19.Emerg Infect Dis2020https://conductscience.org/library/papers/32298228PubMed
232835323Co-infections: potentially lethal and unexplored in COVID-19.Lancet Microbe2020https://conductscience.org/library/papers/32835323PubMed
332314699Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic.Am J Trop Med Hyg2020https://conductscience.org/library/papers/32314699PubMed
419783532BTS guidelines for the management of community acquired pneumonia in adults: update 2009.Thorax2009https://conductscience.org/library/papers/19783532PubMed
532308532First COVID-19 infections in the Philippines: a case report.Trop Med Health2020https://conductscience.org/library/papers/32308532PubMed
623321766Bacterial coinfection in influenza: a grand rounds review.JAMA2013https://conductscience.org/library/papers/23321766PubMed
75092152Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic.Am J Med Sci1971https://conductscience.org/library/papers/5092152PubMed

Download CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
41884792Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study).Ther Adv Infect Dis2026https://conductscience.org/library/papers/41884792PubMed
37887248Secondary and Co-Infections in Hospitalized COVID-19 Patients: A Multicenter Cross-Sectional Study in Malaysia.Antibiotics (Basel)2023https://conductscience.org/library/papers/37887248PubMed
37559639Prevalence of early bacterial co-infection in hospitalized patients with COVID-19 pneumonia: a retrospective study.J Thorac Dis2023https://conductscience.org/library/papers/37559639PubMed
37374189The Dark Side of Nosocomial Infections in Critically Ill COVID-19 Patients.Life (Basel)2023https://conductscience.org/library/papers/37374189PubMed
36654638Prolonged COVID-19 in a Multiple Sclerosis Patient Treated With Rituximab.Cureus2022https://conductscience.org/library/papers/36654638PubMed
36572705Prevalence and characteristics of antibiotic prescription for acute COVID-19 patients in Japan.Sci Rep2022https://conductscience.org/library/papers/36572705PubMed
36557623Incidence and Microbiology of Hospital-Acquired Infections in COVID-19 Patients between the First and the Second Outbreak of the SARS-CoV-2 Pandemic: A Retrospective, Observational Study.Microorganisms2022https://conductscience.org/library/papers/36557623PubMed
36464477SARS-CoV-2 and Legionella pneumophila coinfection.Enferm Infecc Microbiol Clin (Engl Ed)2022https://conductscience.org/library/papers/36464477PubMed
36345840Snapshot of COVID-19 superinfections in Marseille hospitals: where are the common pathogens?Epidemiol Infect2022https://conductscience.org/library/papers/36345840PubMed
36211412Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19.Front Immunol2022https://conductscience.org/library/papers/36211412PubMed
36189314IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA.Front Immunol2022https://conductscience.org/library/papers/36189314PubMed
35723762Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study.Angiogenesis2022https://conductscience.org/library/papers/35723762PubMed
35720435Microbial diversity and antimicrobial susceptibility in endotracheal tube biofilms recovered from mechanically ventilated COVID-19 patients.Biofilm2022https://conductscience.org/library/papers/35720435PubMed
35634338Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.Front Immunol2022https://conductscience.org/library/papers/35634338PubMed
35593963Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19.Mol Biomed2022https://conductscience.org/library/papers/35593963PubMed
35507600Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study.PLoS One2022https://conductscience.org/library/papers/35507600PubMed
35371794Secondary Bacterial Infection Rates Among Patients With COVID-19.Cureus2022https://conductscience.org/library/papers/35371794PubMed
35336074SARS-CoV-2-Legionella Co-Infections: A Systematic Review and Meta-Analysis (2020-2021).Microorganisms2022https://conductscience.org/library/papers/35336074PubMed
35257905Bacterial co-infection at hospital admission in patients with COVID-19.Int J Infect Dis2022https://conductscience.org/library/papers/35257905PubMed
35246169Bacterial and fungal co-infections with SARS-CoV-2 in solid organ recipients: a retrospective study.Virol J2022https://conductscience.org/library/papers/35246169PubMed

See all 43 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32835331

GET https://conductscience.org/api/papers/v1/32835331/cited_by?page=2